Home
About
Overview
Sharing Data
ORCID
Help
History (127)
Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins.
Community Pharmacy Services
Human fructose-1,6-bisphosphatase gene (FBP1): exon-intron organization, localization to chromosome bands 9q22.2-q22.3, and mutation screening in subjects with fructose-1,6-bisphosphatase deficiency.
Genetic aspects of gout.
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.
See All 127 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents. Crit Rev Oncol Hematol. 2005 Oct; 56(1):169-78.
View in:
PubMed
subject areas
Clinical Trials as Topic
Humans
Immunosuppressive Agents
Inflammatory Bowel Diseases
Lymphoma